
|Articles|March 3, 2023
News Roundup: February 27 to March 3
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Eli Lilly Slashing Insulin Prices, Capping Monthly Out of Pocket Costs For Many
The pharmaceutical giant announced a 70% price reduction for most of its commonly sold insulin.
FDA Accepts Verrica's Resumbitted NDA for VP-102
VP-102 hopes to treat molluscum contagiosum, pending approval from FDA
CMS Not Willing To Expand Alzheimer's Drug Coverage
CMS has no plans to change their coverage and approval process, which the Alzheimer's Association believes is standing between patients and treatment.
FDA Accepts Supplemental BLA For Nivolumab For Melanoma
The PDFUA date for the drug is October 13, 2023.
How a Bill Becomes a Law: Pharmacy Legislation to Watch
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
American Pharmacists Month: Pharmacist Barriers, Expansion of Scope Since the COVID-19 Pandemic
2
Community Pharmacies Need to Better Prioritize Whole-Person Health Care | NCPA 2025
3
Pass-Through Rebate Law Uncovering New PBM Tactics, Entities | NCPA 2025
4
Automation Helps Pharmacies Maximize Revenue, Improve Patient Care | NCPA 2025
5


























































































































































